Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Buprenorphine/naloxone (Suboxone) film versus buprenorphine/naloxone tablets for the treatment of opioid addiction: comparative safety. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary of Abstracts. 2014 Authors' conclusions One randomized controlled trial was identified regarding the comparative safety of buprenorphine/naloxone film versus buprenorphine/naloxone tablets for the treatment of prescription opioid addiction in adult patients. Indexing Status Subject indexing assigned by CRD MeSH Buprenorphine; Naloxone; Opioid-Related Disorderss Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: requests@cadth.ca AccessionNumber 32014000831 Date abstract record published 17/07/2014 |